Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells
<p>Abstract</p> <p>Background</p> <p>Ovarian cancer is the most common cause of cancer related death from gynecologic tumors in the United States. The insidious nature of the disease precludes early diagnosis, therefore surgical debulking and chemotherapy are considered...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-05-01
|
Series: | Journal of Ovarian Research |
Online Access: | http://www.ovarianresearch.com/content/3/1/13 |